Format

Send to

Choose Destination
Expert Rev Clin Immunol. 2019 Sep 16:1-5. doi: 10.1080/1744666X.2019.1656526. [Epub ahead of print]

The rise of autologous HCT for autoimmune diseases: what is behind it and what does it mean for the future of treatment? An update on behalf of the EBMT Autoimmune Diseases Working Party.

Author information

1
Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.
2
EBMT Data Office, Department of Haematology, Saint Antoine Hospital - INSERM UMR 938 - Université Pierre et Marie Curie , Paris , France.
3
Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin , Berlin , Germany.

KEYWORDS:

Autoimmune diseases; autologous; bone marrow transplantation; hematopoietic cell transplantation; stem cells

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center